Navigation Links
Kalam Dedicates New Cancer Drug Developed By Biocon

President A P J Abdul Kalam today dedicated to the nation India's first indigenously developed drug for treating head and neck cancer. //

Kalam congratulated Biocon scientists for developing the monoclonal antibody, BioMab EGFR (epidermal growth factor receptor), which company officials said works by binding to cancer cell-specific antigens and inducing an immunological response against the target cell.

Bangalore-based Biocon's chairperson Kiran Mazumdar-Shaw said the 'life-saving cancer drug' will hit the market in the next few months.

Company executives said though a large number of monoclonal antibodies have been launched in the country, they are beyond the reach of a majority of cancer patients because of their prohibitive cost.

They said Biocon's new drug will be effective in several types of cancer that express EGFR, including colo-rectal, pancreatic, metastatic breast, non small cell lung and brain cancers.

'BIOMab EGFR is indicated for use in combination with radiation therapy or chemotherapy in patients with positive expression of EGFR in squamous cell carcinoma of head and neck cancer,' the company said.

Kalam also inaugurated Biocon Park, the country's largest integrated bio-tech hub comprising an integrated cluster of laboratories and manufacturing facilities.

Built with a total investment of Rs 650 crore on a 90-acre plot, the park is the single largest capital investment made by Biocon in its 27-year history.

(Source:PTI News)
'"/>




Page: 1

Related medicine news :

1. Abdul Kalam Confident of AIDS vaccine on Indian market soon
2. Kalam Appeals to Eradicate Hearing Disability
3. Kalam To Lay Foundation Of Vellore Research Center
4. President Kalam Meets Striking Medicos However Stir to Continue
5. President Kalam Meets Striking Medicos However Stir to Continue
6. Abdul Kalam Moved by Orissa Topper’s Eye Disorde
7. Eye Hospital Founder a Beacon Light for Ophthalmologists: Kalam
8. Disabled Girl Urges Kalam to Intervene Against the Denial of Admission
9. Teachers are Creators of Enlightened Citizens in the Country- Dr. A.P.J Abdul Kalam
10. Kalams Intervention Brings Hope to Orissa Student
11. Autistic Children Need Sense of Equality: A.P.J. Abdul Kalam
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from ... in Educational Leadership and Administration at St. Thomas University in Miami, Florida, was ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and more products at customers’ doorstep. According to Smart Mart, customers can now ... stated to offer wearable, and customers can find clothing at discounted prices. Apart ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: